A multicenter trial of two dexamethasone regimens in ventilator- dependent premature infants

New England Journal of Medicine

Volumn 338, Issue 16, 1998, Pages 1112-1118

  Papile, Lu Ann ^a,l   Tyson, Jon E ^b   Stoll, Barbara J ^c   Wright, Linda L ^d   Donovan, Edward F ^e   Bauer, Charles R ^f   Krause Steinrauf, Heidi ^g   Verter, Joel ^g   Korones, Sheldon B ^h   Lemons, James A ⁱ   Fanaroff, Avroy A ^j   Stevenson, David K ^k   Oh, William ^m   Ehrenkranz, Richard A ⁿ   Shankaran, Seetha ^o  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c EMORY UNIVERSITY   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e UNIVERSITY OF CINCINNATI   (United States)

^f UNIVERSITY OF MIAMI   (United States)

^g GEORGE WASHINGTON UNIVERSITY   (United States)

^h UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

ⁱ INDIANA UNIVERSITY   (United States)

^j CASE WESTERN RESERVE UNIVERSITY   (United States)

^k STANFORD UNIVERSITY   (United States)

^l UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^m WOMEN AND INFANTS HOSPITAL   (United States)

ⁿ YALE UNIVERSITY   (United States)

^o WAYNE STATE UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GLUCOSE; PLACEBO;

ARTICLE; ASSISTED VENTILATION; BACTEREMIA; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITAL INFECTION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NECROTIZING ENTEROCOLITIS; NEWBORN; ORAL DRUG ADMINISTRATION; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; VENTILATOR; VERY LOW BIRTH WEIGHT; WEIGHT REDUCTION;

AGE FACTORS; BACTEREMIA; CHRONIC DISEASE; CROSS INFECTION; DEXAMETHASONE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOCORTICOIDS; HUMANS; HYPERGLYCEMIA; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; LUNG DISEASES; MALE; RESPIRATION, ARTIFICIAL; TIME FACTORS; VENTILATOR WEANING;

EID: 0032537074     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199804163381604     Document Type: Article

References (30)

1. Avery GB, Fletcher AB, Kaplan M, Brudno DS. Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics 1985;75:106-11.
2. Mammel MC, Fiterman C, Coleman M, Boros SJ. Short-term dexamethasone therapy for bronchopulmonary dysplasia: acute effects and 1-year follow-up. Dev Pharmacol Ther 1987;10:1-11.
3. Gladstone IM, Ehrenkranz RA, Jacobs HC. Pulmonary function tests and fluid balance in neonates with chronic lung disease during dexamethasone treatment. Pediatrics 1989;84:1072-6.
4. Collaborative Dexamethasone Trial Group. Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Pediatrics 1991;88:421-7.
5. O'Shea TM, Kothadia JM, Klinepeter KL, Goldstein DJ, Jackson B, Dillard RG. Follow-up of preterm infants treated with dexamethasone for chronic lung disease. Am J Dis Child 1993;147:658-61.
6. Jones R, Wincott E, Elbourne D, Grant A. Controlled trial of dexamethasone in neonatal chronic lung disease: a 3-year follow-up. Pediatrics 1995;96:897-906.
7. Kazzi NJ, Brans YW, Poland RL. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation. Pediatrics 1990;86:722-7.
8. Furman L, Hack M, Watts C, et al. Twenty-month outcome in ventilator-dependent, very low birth weight infants born during the early years of dexamethasone therapy. J Pediatr 1995;126:434-40.
9. Cummings JJ, D'Eugenio DB, Gross SJ. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med 1989;320:1505-10.
10. Yeh TF, Torre JA, Rastogi A, Anyebuno MA, Pildes RS. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind controlled study. J Pediatr 1990;117:273-82.
11. Durand M, Sardesai S, McEvoy C. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial. Pediatrics 1995;95: 584-90.
12. Yeh TF, Lin IJ, Shieh WS, et al. Prevention of chronic lung disease (CLD) with dexamethasone (D) - a new therapeutic regimen. Pediatr Res 1995;37:Suppl:247A. abstract.
13. Rastogi A, Akintorin SM, Bez ML, Morales P, Pildes RS. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants. Pediatrics 1996;98:204-10.
14. Shinwell ES, Karplus M, Zmora E, et al. Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed 1996;74:F33-F37.
15. Papile L-A, Krause-Steinrauf H, Wright LL, et al. Identification of very low birthweight infants (VLBW) at risk for chronic lung disease (CLD). Pediatr Res 1994;35:Suppl:246A. abstract.
16. Wei LJ, Lachin JM. Properties of the urn randomization in clinical trials. Controlled Clin Trials 1988;9:345-64.
17. Assadi FK, Norman ME. Neonatal hypertension and renovascular disease. In: Spitzer AR, ed. Intensive care of the fetus and neonate. St. Louis: Mosby-Year Book, 1996:1050-5.
18. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis: therapeutic decisions based on clinical staging. Ann Surg 1978;187: 1-7.
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
20. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983;70:659-63.
21. Sackett DL, Gent M. Controversy in counting and attributing events in clinical trials. N Engl J Med 1979;301:1410-2.
22. Guyatt GH, Sackett DL, Cook DJ. Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? JAMA 1994; 271:59-63.
23. Marinelli KA, Burke GS, Herson VC. Effects of dexamethasone on blood pressure in premature infants with bronchopulmonary dysplasia. J Pediatr 1997;130:594-602.
24. Ng PC, Thomson MA, Dear PRF. Dexamethasone and infection in premature babies: a controlled study. Arch Dis Child 1990;65:54-6.
25. Stoll B, Gordon T, Korones SB, et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996; 129:63-71.
26. Weichsel ME Jr. The therapeutic use of glucocorticoid hormones in the perinatal period: potential neurologic hazards. Ann Neurol 1977;2: 364-6.
27. Cotterrell M, Balazs R, Johnson AL. Effects of corticosteroids on the biochemical maturation of rat brain: postnatal cell formation. J Neurochem 1972;19:2151-67.
28. Yeh TF, Lin YJ, Lin CH, et al. Early postnatal (<12 hrs) dexamethasone (D) therapy for prevention of BPD in preterm infants with RDS - a two year follow-up study. Pediatr Res 1997;41:188A. abstract.
29. O'Shea TM, Kothadia JM, Goldstein DJ, Klinepeter KL, Dillard RG. Effect of a 42-day tapering course of dexamethasone on outcome at one year of age in very preterm infants. Pediatr Res 1997;41:207A. abstract.
30. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med 1987;317:141-5.